|Day's Range||3.54 - 3.58|
|52 Week Range||3.31 - 5.80|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Unique value, no catalyst, net cash 64% of market cap, insider buying, 52-week low: Acacia Research
Acacia Research Corporation announced today that Acacia Research Group LLC and its LifePort Sciences LLC subsidiary have entered into a license agreement with Medtronic, Inc.
The Newport Beach, California-based company said it had a loss of 24 cents per share. Losses, adjusted for amortization costs and stock option expense, came to 8 cents per share. The technology patent ...